Abstract
Inflammation within areas of interstitial fibrosis and tubular atrophy (i-IFTA) is associated with adverse outcomes in kidney transplantation. We evaluated i-IFTA in 429 indication- and 2052 protocol-driven biopsy samples from a longitudinal cohort of 362 kidney–pancreas recipients to determine its prevalence, time course, and relationships with T cell–mediated rejection (TCMR), immunosuppression, and outcome. Sequential histology demonstrated that i-IFTA was preceded by cellular interstitial inflammation and followed by IF/TA. The prevalence and intensity of i-IFTA increased with developing chronic fibrosis and correlated with inflammation, tubulitis, and immunosuppression era (P
Author supplied keywords
Cite
CITATION STYLE
Nankivell, B. J., Shingde, M., Keung, K. L., Fung, C. L. S., Borrows, R. J., O’Connell, P. J., & Chapman, J. R. (2018). The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion. American Journal of Transplantation, 18(2), 364–376. https://doi.org/10.1111/ajt.14609
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.